Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Cantor Fitzgerald Maintains Biohaven Pharmaceutical Holding (BHVN) Overweight Recommendation
On April 4, 2023, Cantor Fitzgerald maintained coverage of Biohaven Pharmaceutical Holding with a Overweight recommendation. Analyst Price Forecast Suggests 77.58% Upside As of March
Stephens & Co. Initiates Coverage of United Community Banks (UCBI) with Overweight Recommendation
On April 4, 2023, Stephens & Co. initiated coverage of United Community Banks with a Overweight recommendation. Analyst Price Forecast Suggests 30.14% Upside As of
Stephens & Co. Initiates Coverage of 10x Genomics, Inc. (TXG) with Overweight Recommendation
On March 31, 2023, Stephens & Co. initiated coverage of 10x Genomics, Inc. with a Overweight recommendation. Analyst Price Forecast Suggests 5.48% Downside As of
Piper Sandler Initiates Coverage of Immunovant (IMVT) with Overweight Recommendation
On March 31, 2023, Piper Sandler initiated coverage of Immunovant with a Overweight recommendation. Analyst Price Forecast Suggests 56.52% Upside As of March 30, 2023,
EPS recession is coming; Citi upgrades U.S. equities, Tech to Overweight By Investing.com
© Reuters. EPS recession is coming; Citi upgrades US equities, Tech to Overweight By Senad Karaahmetovic Citi analysts are growing increasingly more positive on U.S.
Wells Fargo Initiates Coverage of UDR (UDR) with Overweight Recommendation
On March 29, 2023, Wells Fargo initiated coverage of UDR with a Overweight recommendation. Analyst Price Forecast Suggests 23.08% Upside As of March 28, 2023,
Morgan Stanley Initiates Coverage of Model N (MODN) with Overweight Recommendation
On March 27, 2023, Morgan Stanley initiated coverage of Model N with a Overweight recommendation. Analyst Price Forecast Suggests 51.64% Upside As of March 26,